Beryl Drugs - Quarterly Results
12th Feb 2019

The sales slipped to Rs. 30.11 millions for the December 2018 quarter as against Rs. 36.35 millions during the year-ago period.A good growth in profit of 41.18% reported to Rs. 1.44  millions over Rs. 1.02 millions of corresponding previous quarter.The company reported a good operating profit of 3.48 millions compared to 2.53 millions of corresponding previous quarter.



(Rs. in Million)


  Quarter ended Year to Date Year ended
  201812 201712 % Var 201812 201712 % Var 201803 201703 % Var
Sales 30.11 36.35 -17.17 107.94 117.59 -8.21 159.87 115.29 38.67
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 3.48 2.53 37.55 10.97 7.66 43.21 16.90 2.18 675.23
Interest 0.75 0.21 257.14 1.74 0.89 95.51 1.32 2.01 -34.33
PBDT 2.73 2.32 17.67 9.22 6.77 36.19 15.58 0.16 9637.50
Depreciation 0.71 1.00 -29.00 2.13 3.00 -29.00 3.30 3.77 -12.47
PBT 2.02 1.32 53.03 7.09 3.77 88.06 12.28 -3.61 -440.17
TAX 0.58 0.30 93.33 2.22 0.92 141.30 2.34 0.53 341.51
Deferred Tax 0.10 0.00 0.00 0.45 0.00 0.00 -0.26 -0.34 -23.53
PAT 1.44 1.02 41.18 4.87 2.85 70.88 9.93 -4.14 -339.86
Equity 50.72 50.72 0.00 50.72 50.72 0.00 50.72 50.72 0.00
PBIDTM(%) 11.56 6.96 66.06 10.16 6.51 56.01 10.57 1.88 461.64